Plain-English translation of NCT07721142 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether , a traditional Chinese herbal medicine, works better when combined with two standard arthritis medications (methotrexate and tofacitinib) to treat severe rheumatoid arthritis that hasn't responded to other treatments. About half of participants will receive the real medication while the other half receive a placebo (a fake pill that looks identical), so researchers can see if the treatment truly makes a difference. Everyone will be monitored closely over 6 months to measure pain, swelling, and overall improvement.
Many people with rheumatoid arthritis don't get enough relief from standard Western medicines alone, and their joints continue to suffer damage. This trial explores whether combining traditional Chinese medicine with conventional treatments might offer better results and help doctors develop more effective treatment strategies.
You likely qualify if…
You likely don't qualify if…
You will visit the study clinic multiple times over 6 months. For the first 12 weeks, you'll either receive the herbal capsule three times daily along with your standard arthritis medications, or a placebo capsule with the same medications—you won't know which. After 12 weeks, everyone switches to receiving the actual herbal treatment combined with the standard medications for another 12 weeks. At each visit, doctors will examine your joints, check blood work to measure inflammation, and ask about your symptoms and any side effects.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
China